Stroke survivors and their relatives consistently ask for information about how much recovery can be expected. This study will look at how well a patient can use their arm after stroke, and at their brain images recorded within 72-hours after stroke. The hope is that brain images can improve our prediction of patient arm movement recovery at six months after stroke.
Development of new magnetic resonance imaging (MRI) techniques to image vessel patterns and blood flow in patients with disease of their vertebral arteries
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.
Testing the idea that fatigue occurring after stroke is due to changes in the brain regions controlling the muscles using non-invasive brain stimulation and brain imaging techniques in 142 stroke patients, half of who will be those who complain of fatigue.
The aim of this research programme is to develop a human brain bank to support biomedical research into the pathophysiology of human SVD that may be used nationally and internationally.
In this study we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
Do Naturally Produced Cells in the Brain Contribute to Repairing the Damage Done by Stroke?
Magnetic resonance imaging (MRI) scans provide lots of data on the health of a person’s brain, not all of which is routinely used in clinical practice. This project will continue the development of tools to assess the brain scans of people with stroke.
Apathy has a major effect of quality of life for a SVD sufferer; we have shown that for the patient it is more important in determining quality of life than is disability, such as weakness, from the stroke itself.
The Stroke Association works with and for stroke survivors. We work with all stakeholders who have an interest in stroke, including the pharmaceutical industry, to achieve a common goal - to conquer stroke. Our guidelines ensure our approach to working with pharmaceutical companies is transparent and cannot compromise our independence.